Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus.
Hirano D, Kato H, Kodaira T, Yatabe Y, Ueda N, Murakami S, Higuchi Y, Taji H, Nakamura S, Yamamoto K, Kinoshita T. Hirano D, et al. Among authors: higuchi y. Ann Hematol. 2015 Jan;94(1):173-5. doi: 10.1007/s00277-014-2128-7. Epub 2014 Jun 20. Ann Hematol. 2015. PMID: 24947796 No abstract available.
Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
Murakami S, Kato H, Higuchi Y, Yamamoto K, Yamamoto H, Saito T, Taji H, Yatabe Y, Nakamura S, Kinoshita T. Murakami S, et al. Among authors: higuchi y. Ann Hematol. 2016 Aug;95(8):1259-69. doi: 10.1007/s00277-016-2690-2. Epub 2016 May 25. Ann Hematol. 2016. PMID: 27220639
Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma.
Maruyama D, Hatake K, Kinoshita T, Fukuhara N, Choi I, Taniwaki M, Ando K, Terui Y, Higuchi Y, Onishi Y, Abe Y, Kobayashi T, Shirasugi Y, Tobinai K. Maruyama D, et al. Among authors: higuchi y. Cancer Sci. 2017 May;108(5):1007-1012. doi: 10.1111/cas.13230. Epub 2017 May 19. Cancer Sci. 2017. PMID: 28267244 Free PMC article. Clinical Trial.
Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study.
Kinoshita T, Hatake K, Yamamoto K, Higuchi Y, Murakami S, Terui Y, Yokoyama M, Maruyama D, Makita S, Hida Y, Saito T, Tobinai K. Kinoshita T, et al. Among authors: higuchi y. Jpn J Clin Oncol. 2021 Jan 1;51(1):70-77. doi: 10.1093/jjco/hyaa169. Jpn J Clin Oncol. 2021. PMID: 33029633 Free PMC article. Clinical Trial.
1,758 results